NATIONAL BESTSELLER ? The gripping story of Elizabeth Holmes and Theranos -- one of the biggest corporate frauds in history -- a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword covering her trial and sentencing, bringing the story to a close.

"Chilling... Reads like a thriller... Carreyrou tells [the Theranos story] virtually to perfection." -- The New York Times Book Review

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.5 billion. There was just one problem: The technology didn't work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings -- from journalists to their own employees.

• We started tracking this book on March 15, 2018.
• This book was $13.99 when we started tracking it.
• The price of this book has changed 43 times in the past 2,436 days.
• The current price of this book is $13.99 last checked one day ago.
• This lowest price this book has been offered at in the past year is $1.99.
• The lowest price to date was $1.99 last reached on November 10, 2024.
• This book has been $1.99 3 times since we started tracking it.
• The highest price to date was $14.99 last reached on May 6, 2024.
• This book has been $14.99 6 times since we started tracking it.

• Business & Money

• Text-to-Speech: Disabled
• Lending: Disabled
• Print Length: 353 Pages
• File Size: 13,644 KB